Volume 10, Supplement 1 (Mar 2019)
Volume 10, Supplement 1 (Mar 2019)
Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events
This supplement, certified for CME/CE/CPE credit, is jointly provided by:



Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care
March 17, 2019
PD-1/PD-L1 Inhibitors for Non–Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Checkpoint Inhibitor Immunotherapy for Head and Neck Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
March 17, 2019
Advertisement
Current Issue
Vol 16
No 6
Nov/Dec 2025
JADPRO Live 2025 United in Care
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO
November 12, 2025
Assessment of Standards of Care for Oral Chemotherapy by Pharmacists in Clinical Settings
Sara Nezirevic, PharmD, MPH, Benyam Muluneh, PharmD, BCOP, CPP, Jennifer Elston Lafata, PhD, Et al.
November 10, 2025
Advanced Practice Provider Led Trials in Radiation Oncology Are We Missing the Opportunity
Molly K. Tate, PhD, APRN, FNP-C
November 10, 2025